Hem/Onc
Pulm/Crit
Infectious Dx
Nephrology
Cardio
100

Predictive score for VTE risk in cancer patients

Khorana score

100
Daytime PCO2 levels associated with OHS

>45

100

Non severe respiratory illness caused by legionella

Pontiac fever

100

antibody associated with membranous nephropathy

 Phospholipase A2 receptor antibody

100

late gadolinium enhancement associated with this condition

myocarditis

200

Length of Superficial Venous thrombosis requiring anticoagulation

5cm or more

200

Asthma phenoytpe associated with increased eosinophil and IgE levels

Th2 phenotype

200

infectious agent for nsc fascitis associated with fresh water exposure

Aeromonas hydrophila

200

Autosomal dominant disorder caused by mutation of genes coding for the alpha-3 or alpha-4 chains of type IV collagen

thin basement membrane disease

200

Cardiac condition associated with Carney complex

atrial myxoma

300

Increased risk of TLS is assessed with this score

Cairo-Bishop score

300

Treatment for tuberculosis that introduced inert substances into the pleural space to force physical collapse of the affected lobes

 Plombage (accept extraperiosteal or extrapleural pnemonolysis)

300

Treatment of choice for variola virus infection

Tecovirimat

300

A circulating peptide secreted by osteocytes and osteoblasts that causes renal phosphate wasting

FGF23

300

ARNI were approved for HFpEF based on this trial

PARAGON-HF

400

2 genes in JAK-negative essential thrombocythemia  

MPL and calreticulin

400

Vitamin supplement associated with EVALI

Vitamin E acetate

400

Tick borne illness associated with Amblyomma americanum bite

STARI

400

Albumin level associated with increased risk of VTE in membranous nephropathy

<2.5

400

The EVEREST trial showed the effectiveness of this medication in CHF symptom improvement

TOLVAPTAN

500

SUSTAIN TRIAL showed this monoclonal antibody as effective in SCDx

Crizanlizumab

500

Pulmonary alveloar proteinosis is associated with this metal exposure

Indium

500

TB agent associated with heater-cooler units used during cardiac surgery.



Mycobacterium chimaera

500

This trial showed the effectiveness of Tolvaptan at slowing GFR decline in ADPKD

TEMPO trial

500

cardiac procedure for replacement of aortic valve, aortic root and ascending aorta with graft

BENTALL PROCEDURE

M
e
n
u